|
|
 32 bioprospecting extract DHJanzen100042.jpg high resolution
|
|
| The extracted insects (or plants, or fungi, or......), the biodiversity prospecting sample, ready for delivery to Merck for further purification, screening, analysis - and in rare cases, 10-20 years later, a prescription drug. And if so, then a 5% royalty would accrue to INBio or whatever in-country entity had entered into a biodiversity prospecting contract with INBio. And the original contract just to get the samples themselves was $1m-plus per two years - all funds that were spent in-country on salaries, equipment, training and other forms of national income as a direct form of farming wild biodiversity. | ||
back to lecture slides
or skip to: